Open Accessibility Menu

Head & Neck

NRG – HN005 at

A randomized Phase II/III trial of de-intensified radiation therapy for patients with early-stage, P16-positive, non-smoking associated oropharyngeal cancer (GEP-NET)

Cancer Type: Oropharynx, squamous cell, P16+

Principal Investigator: Dr. Debra Brandt

Please contact Clinical Trials Office for more details: 561-263-5791

  • Jupiter Medical Center

    We want to help you! If you have questions about our services and what we can offer you and your loved ones, please reach out.